Welcome, Guest
Register
Sign In
Member Center
Sign Out
Register
Sign In
Go
Symbol Lookup
Loading...
Go
HOME
NEWS
U.S.
Asia
Europe
Economy
Energy
Inside Wealth
Politics
Technology
Blogs
Slideshows
Special Reports
Corrections
MARKETS
Pre-Markets
US
Europe
Asia
Stocks
Commodities
Currencies
Bonds
Funds
ETFs
EARNINGS
Calendar
Surprises
Highlights
INVESTING
Stock Blog
Personal Finance
CNBC Explains
Portfolio
Watchlist
Stock Screener
Fund Screener
Small Business
Franchising
Financing
Management
Video
VIDEO
Latest Video
Top Video
U.S. Video
Europe Video
Asia Video
CEO Interviews
Analyst Interviews
CNBC Digital Workshop
CNBC TV
CNBC U.S.
CNBC Asia-Pacific
CNBC Europe
CNBC World
CNBC Pro
Salix Pharmaceuticals Ltd
U.S. FDA new drug approvals hit 16-year high in 2012
Monday, 31 Dec 2012 | 3:50 PM ET
*FDA says pipeline for new drugs strong. *Major approvals for Pfizer, Bristol Myers-Squibb.
Top News and Analysis
How the Smartphone Killed the Three-Day Weekend
Yes, Mr. Jones. Mothers Can Be Great Traders
A First: Per-Student Spending Down at Schools
Yahoo Joins Growing List of Hulu Bidders
More Evidence Banks Violated Mortgage Pact: NY AG
CNBC Disruptor 50 Innovators
Summer Sun, Summer Fun, in a Virtual Era
Busting the Telecom Monopoly, With a 99-Cent App
50 Disruptor Companies Changing the Business World
New York's 11 Largest Venture-Backed Exits
Tecnology Companies Down-Shifting Road Rage
Most Popular Stories
‘One of the Last Great Opportunities’
Midday Movers: VRX, FNMA, ABX & More
Oil Prices, Dollar May Set Off on New Relationship
Trump Beats Rap From 87-Year-Old Grandma
Watching for Signs of a Too-Strong US Economy
Most Popular Video
Bridge Collapses, Survivors Speak
Lafley Back at P&G
Are Currency Wars a Concern?
Larry Bossidy on Immigration Reform
Fed's Tapering Could Be Very Slow: Bullard